found that demethylating therapy could increase the CD123 expression on leukemia cells and increase CTLA4- CD123 CAR-T cell proportion and showed superior cytotoxicity against AML cells, accompanied by higher TNFα production in leukemia-bearing mice (116). The gene discussed is CTLA4; the disease is leukemia.